# Open-label Clinical Trial to Investigate the Safety and Tolerability of Allogeneic B-cell Concentrates for Immune Reconstitution After Allogeneic Stem Cell Transplantation Measured as Response to a Antedated Single Vaccination

> **NCT02007811** · PHASE1,PHASE2 · UNKNOWN · sponsor: **University of Erlangen-Nürnberg Medical School** · enrollment: 15 (estimated)

## Conditions studied

- Acute Myeloid Leukemia
- Acute Lymphoblastic Leukemia
- Chronic Myeloid Leukemia
- Non Hodgkin's Lymphoma
- Hodgkin's Disease
- Myelodysplastic Syndrome
- Multiple Myeloma
- Aplastic Anemia

## Interventions

- **BIOLOGICAL:** allogeneic donor derived B-lymphocytes

## Key facts

- **NCT ID:** NCT02007811
- **Lead sponsor:** University of Erlangen-Nürnberg Medical School
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2013-11
- **Primary completion:** 2015-12
- **Final completion:** 2015-12
- **Target enrollment:** 15 (ESTIMATED)
- **Last updated:** 2014-03-26

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02007811

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02007811, "Open-label Clinical Trial to Investigate the Safety and Tolerability of Allogeneic B-cell Concentrates for Immune Reconstitution After Allogeneic Stem Cell Transplantation Measured as Response to a Antedated Single Vaccination". Retrieved via AI Analytics 2026-06-21 from https://api.ai-analytics.org/clinical/NCT02007811. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*